SCHEMBL25680758

SCHEMBL25680758

c1ccc(-c2ccc3cc(-c4nc(-c5ccccc5)nc(-c5cccc(-c6cccc7cc(-c8ccccc8)ccc67)c5)n4)ccc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 4/20 0.43
HSD17B2 P37059 4/20 0.43
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
TP53 P04637 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP1A2 P05177 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ESR1 P03372 4/20 0.41
ESR2 Q92731 4/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25680783 0.98 ALDH1A1 (0.44) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL25680782 0.97 ALDH1A1 (0.46) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL21667499 0.97 ALDH1A1 (0.45) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL24377091 0.95 HSD17B1 (0.45) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL16785880 0.95 HSD17B1 (0.46) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL24770249 0.94 CA12 (0.48) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL25680745 0.94 CA12 (0.45) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL25471687 0.94 ALDH1A1 (0.48) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL17655824 0.94 HSD17B1 (0.47) HSD17B1HSD17B2ALDH1A1KDM4ETP53
SCHEMBL24770267 0.94 ALDH1A1 (0.48) HSD17B1HSD17B2ALDH1A1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof ESR1, EML4, ORAI2 HSD17B1 1405/4885HSD17B2 929/4885ALDH1A1 601/4885
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF ESR1, EML4, ORAI2 HSD17B1 1405/4885HSD17B2 929/4885ALDH1A1 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.